CHD5 and cancer: Consistently, heterozygous deletion of the CHD5 gene as well as the promoter CpG island hypermethylation is frequently observed in various human cancers [101,102], suggesting that inactivation of CHD5 caused by deletion and epigenetic silencing commits to tumorigenesis and tumor progression.